Literature DB >> 21141734

Small molecules in cellular reprogramming and differentiation.

Xu Yuan1, Wenlin Li, Sheng Ding.   

Abstract

Recent advances in somatic cell reprogramming and directed differentiation make it possible to generate patient-specific pluripotent cells and further derive functional tissue-specific cells for biomedical research and future therapies. Chemical compounds targeting enzymes or signaling proteins are powerful tools to regulate and reveal complex cellular processes and have been identified and applied to controlling cell fate and function, including stem cell maintenance, differentiation, and reprogramming. Not only are small molecules useful in generating desired cell types in vitro for various applications, but also such small molecules could be further developed as conventional therapeutics to target patient's own cells residing in different tissues/organs for treating degenerative diseases, injuries, and cancer. Here, we will review recent studies of small molecules in controlling cell fate.

Entities:  

Mesh:

Year:  2011        PMID: 21141734     DOI: 10.1007/978-3-7643-8989-5_13

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


  8 in total

Review 1.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

2.  Simultaneous suppression of TGF-β and ERK signaling contributes to the highly efficient and reproducible generation of mouse embryonic stem cells from previously considered refractory and non-permissive strains.

Authors:  Seyedeh-Nafiseh Hassani; Mehdi Totonchi; Ali Farrokhi; Adeleh Taei; Mehran Rezaei Larijani; Hamid Gourabi; Hossein Baharvand
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

3.  An automated high throughput screening-compatible assay to identify regulators of stem cell neural differentiation.

Authors:  Laura Casalino; Dario Magnani; Sandro De Falco; Stefania Filosa; Gabriella Minchiotti; Eduardo J Patriarca; Dario De Cesare
Journal:  Mol Biotechnol       Date:  2012-03       Impact factor: 2.695

4.  A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.

Authors:  Hananeh Fonoudi; Hassan Ansari; Saeed Abbasalizadeh; Mehran Rezaei Larijani; Sahar Kiani; Shiva Hashemizadeh; Ali Sharifi Zarchi; Alexis Bosman; Gillian M Blue; Sara Pahlavan; Matthew Perry; Yishay Orr; Yaroslav Mayorchak; Jamie Vandenberg; Mahmood Talkhabi; David S Winlaw; Richard P Harvey; Nasser Aghdami; Hossein Baharvand
Journal:  Stem Cells Transl Med       Date:  2015-10-28       Impact factor: 6.940

5.  Biomimetic platforms for human stem cell research.

Authors:  Gordana Vunjak-Novakovic; David T Scadden
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

Review 6.  Human pluripotent stem cell-derived retinal pigmented epithelium in retinal treatment: from bench to bedside.

Authors:  Maryam Parvini; Leila Satarian; Kazem Parivar; Mohammad Javan; Mahdi Tondar; Sajjad Ahmad; Hossein Baharvand
Journal:  Mol Neurobiol       Date:  2014-04-03       Impact factor: 5.590

7.  Effects of DNMT1 and HDAC inhibitors on gene-specific methylation reprogramming during porcine somatic cell nuclear transfer.

Authors:  Weihua Xu; Zicong Li; Bo Yu; Xiaoyan He; Junsong Shi; Rong Zhou; Dewu Liu; Zhenfang Wu
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  Generation of Induced Pluripotent Stem (iPS) Cells by Nuclear Reprogramming.

Authors:  Dilip Dey; Gregory R D Evans
Journal:  Stem Cells Int       Date:  2011-10-05       Impact factor: 5.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.